Phathom Pharmaceuticals, Inc. PHAT Total debt
Total debt at other companies
Other financials
Where this comes from
Calculated from Phathom Pharmaceuticals, Inc.’s reported figures.
Plus components not separately reported this period.
The official record: Phathom Pharmaceuticals, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Phathom Pharmaceuticals, Inc.'s total debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Phathom Pharmaceuticals, Inc.'s total debt?
- Phathom Pharmaceuticals, Inc. (PHAT) reported total debt of $166.3M in Q1 2026.
- How has Phathom Pharmaceuticals, Inc.'s total debt changed year-over-year?
- Phathom Pharmaceuticals, Inc.'s total debt decreased by 18.3% year-over-year, from $203.56M to $166.3M.
- What is the long-term trend for Phathom Pharmaceuticals, Inc.'s total debt?
- Over 5 years (2020 to 2025), Phathom Pharmaceuticals, Inc.'s total debt has grown at a 34.0% compound annual growth rate (CAGR), from $49.02M to $211.8M.
- What does total debt mean?
- Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.